The path forward in early-stage lung cancer
- PMID: 36762062
- PMCID: PMC9903095
- DOI: 10.21037/tlcr-22-546
The path forward in early-stage lung cancer
Keywords: Early-stage lung cancer; perioperative immune checkpoint inhibition; perioperative strategy; perioperative targeted therapy.
Conflict of interest statement
Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://tlcr.amegroups.com/article/view/10.21037/tlcr-22-546/coif). The authors have no conflicts of interest to declare.
Comment on
-
Expert consensus on perioperative treatment for non-small cell lung cancer.Transl Lung Cancer Res. 2022 Jul;11(7):1247-1267. doi: 10.21037/tlcr-22-527. Transl Lung Cancer Res. 2022. PMID: 35958323 Free PMC article. Review. No abstract available.
References
-
- Eberhardt WEE, Mitchell A, Crowley J, et al. The IASLC lung cancer staging project: proposals for the revision of the M descriptors in the forthcoming eighth edition of the TNM classification of lung cancer. J Thorac Oncol 2015;10:1515-22. - PubMed
Publication types
LinkOut - more resources
Full Text Sources